Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne 3800, Victoria, Australia.
School of Biological Sciences, Monash University, Melbourne 3800, Victoria, Australia.
Biol Chem. 2019 Nov 26;400(12):1603-1616. doi: 10.1515/hsz-2018-0391.
In human α1-antitrypsin deficiency, homozygous carriers of the Z (E324K) mutation in the gene SERPINA1 have insufficient circulating α1-antitrypsin and are predisposed to emphysema. Misfolding and accumulation of the mutant protein in hepatocytes also causes endoplasmic reticulum stress and underpins long-term liver damage. Here, we describe transgenic zebrafish (Danio rerio) expressing the wildtype or the Z mutant form of human α1-antitrypsin in hepatocytes. As observed in afflicted humans, and in rodent models, about 80% less α1-antitrypsin is evident in the circulation of zebrafish expressing the Z mutant. Although these zebrafish also show signs of liver stress, they do not accumulate α1-antitrypsin in hepatocytes. This new zebrafish model will provide useful insights into understanding and treatment of α1-antitrypsin deficiency.
在人类α1-抗胰蛋白酶缺乏症中,SERPINA1 基因中 Z(E324K)突变的纯合子携带者循环中的α1-抗胰蛋白酶不足,易患肺气肿。突变蛋白在肝细胞中的错误折叠和积累也会导致内质网应激,并构成长期肝损伤的基础。在这里,我们描述了在肝细胞中表达野生型或 Z 突变型人α1-抗胰蛋白酶的转基因斑马鱼(Danio rerio)。正如在受影响的人类和啮齿动物模型中观察到的那样,表达 Z 突变体的斑马鱼中循环中的α1-抗胰蛋白酶明显减少了约 80%。尽管这些斑马鱼也表现出肝应激的迹象,但它们不会在肝细胞中积累α1-抗胰蛋白酶。这种新的斑马鱼模型将为理解和治疗α1-抗胰蛋白酶缺乏症提供有用的见解。